Geode Capital Management’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $84.1M | Buy |
1,789,449
+73,997
| +4% | +$3.48M | 0.01% | 1129 |
|
2025
Q1 | $75.7M | Buy |
1,715,452
+45,244
| +3% | +$2M | 0.01% | 1141 |
|
2024
Q4 | $60.4M | Sell |
1,670,208
-39
| -0% | -$1.41K | ﹤0.01% | 1311 |
|
2024
Q3 | $53.5M | Buy |
1,670,247
+109,189
| +7% | +$3.5M | ﹤0.01% | 1386 |
|
2024
Q2 | $58.8M | Buy |
1,561,058
+56,355
| +4% | +$2.12M | 0.01% | 1249 |
|
2024
Q1 | $74.1M | Buy |
1,504,703
+85,615
| +6% | +$4.21M | 0.01% | 1109 |
|
2023
Q4 | $51.8M | Buy |
1,419,088
+236,978
| +20% | +$8.65M | 0.01% | 1326 |
|
2023
Q3 | $27.3M | Buy |
1,182,110
+128,944
| +12% | +$2.98M | ﹤0.01% | 1624 |
|
2023
Q2 | $27.6M | Buy |
1,053,166
+224,708
| +27% | +$5.89M | ﹤0.01% | 1644 |
|
2023
Q1 | $21.3M | Buy |
828,458
+28,679
| +4% | +$738K | ﹤0.01% | 1757 |
|
2022
Q4 | $20.8M | Buy |
799,779
+180,885
| +29% | +$4.7M | ﹤0.01% | 1748 |
|
2022
Q3 | $17.7M | Buy |
618,894
+61,230
| +11% | +$1.75M | ﹤0.01% | 1827 |
|
2022
Q2 | $13.7M | Buy |
557,664
+44,356
| +9% | +$1.09M | ﹤0.01% | 2031 |
|
2022
Q1 | $29M | Buy |
513,308
+20,970
| +4% | +$1.18M | ﹤0.01% | 1634 |
|
2021
Q4 | $30.5M | Buy |
492,338
+4,902
| +1% | +$304K | ﹤0.01% | 1690 |
|
2021
Q3 | $30.9M | Sell |
487,436
-16,133
| -3% | -$1.02M | ﹤0.01% | 1674 |
|
2021
Q2 | $41.5M | Buy |
503,569
+55,435
| +12% | +$4.57M | 0.01% | 1470 |
|
2021
Q1 | $33M | Buy |
448,134
+42,323
| +10% | +$3.11M | 0.01% | 1535 |
|
2020
Q4 | $29.4M | Buy |
405,811
+67,937
| +20% | +$4.93M | ﹤0.01% | 1469 |
|
2020
Q3 | $16.1M | Buy |
337,874
+100,650
| +42% | +$4.8M | ﹤0.01% | 1679 |
|
2020
Q2 | $9.96M | Buy |
237,224
+76,611
| +48% | +$3.22M | ﹤0.01% | 1922 |
|
2020
Q1 | $4.34M | Buy |
160,613
+29,016
| +22% | +$783K | ﹤0.01% | 2226 |
|
2019
Q4 | $5.07M | Buy |
+131,597
| New | +$5.07M | ﹤0.01% | 2444 |
|